Company Rockwell Medical, Inc.

Equities

RMTI

US7743743004

Pharmaceuticals

Market Closed - Nasdaq 04:00:00 2024-03-28 pm EDT 5-day change 1st Jan Change
1.66 USD +1.22% Intraday chart for Rockwell Medical, Inc. +9.21% -12.17%

Business Summary

Rockwell Medical, Inc. is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers around the world. It operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. It is the supplier of life-sustaining hemodialysis concentrates products to dialysis clinics. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. Its first two branded products from its ferric pyrophosphate citrate (FPC) platform, Triferic (dialysate) and Triferic AVNU, are indicated to maintain hemoglobin in patients undergoing hemodialysis. It offers dry and liquid citric acid, acetic acid, and bicarbonate hemodialysis products.

Number of employees: 237

Sales per Business

USD in Million2022Weight2023Weight Delta
Concentrate Products
97.2 %
72 98.4 % 81 97.2 % +13.43%
Drug
2.8 %
1 1.6 % 2 2.8 % +101.73%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
88.9 %
66 90.3 % 74 88.9 % +13.04%
Rest of World
11.1 %
7 9.7 % 9 11.1 % +31.57%

Managers

Managers TitleAgeSince
Chief Executive Officer 53 22-06-30
Director of Finance/CFO - 23-10-17
Chief Tech/Sci/R&D Officer 63 19-11-19
Sales & Marketing - 19-11-30
Corporate Officer/Principal - 18-12-09
General Counsel 52 21-07-31
Corporate Officer/Principal - 22-09-06

Members of the board

Members of the board TitleAgeSince
Director/Board Member 65 17-09-06
Director/Board Member 77 20-06-10
Chief Executive Officer 53 22-06-30
Chairman 60 20-03-30
Director/Board Member 54 23-10-16
Director/Board Member 71 17-05-31
Director/Board Member 56 20-12-10

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 29,334,617 28,453,128 ( 97.00 %) 0 97.00 %

Shareholders

NameEquities%Valuation
Armistice Capital LLC
6.501 %
1,852,000 6.501 % 3 M $
1,365,000 4.791 % 2 M $
Vanguard Global Advisers LLC
3.773 %
1,074,975 3.773 % 2 M $
548,224 1.924 % 772 996 $
Richmond Brothers, Inc.
1.448 %
412,433 1.448 % 581 531 $
Perkins Capital Management, Inc.
1.228 %
349,934 1.228 % 493 407 $
Geode Capital Management LLC
0.9966 %
283,923 0.9966 % 400 331 $
Raymond James & Associates, Inc.
0.7756 %
220,979 0.7756 % 311 580 $
BlackRock Institutional Trust Co. NA
0.6173 %
175,871 0.6173 % 247 978 $
Marshall Wace LLP
0.6146 %
175,096 0.6146 % 246 885 $

Company contact information

Rockwell Medical, Inc.

30142 South Wixom Road

48393, Wixom

+248 960 9009

http://www.rockwellmed.com
address Rockwell Medical, Inc.(RMTI)

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
1.66 USD
Average target price
7 USD
Spread / Average Target
+321.69%
Consensus